Bradley Mark J. Abiomed Inc Transaction History

Bradley Mark J.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$242.49 - $301.46 $12,124 - $15,072	50 Added 0.54%	9,375 $2.3 Million
Q2 2022 Jul 15, 2022	SELL	$224.73 - $338.64 $11,236 - $16,932	-50 Reduced 0.53%	9,325 $2.31 Million
Q1 2022 May 12, 2022	BUY	$277.25 - $366.29 $24,952 - $32,966	90 Added 0.97%	9,375 $3.11 Million
Q4 2021 Mar 07, 2022	SELL	$300.63 - $371.35 $34,572 - $42,705	-115 Reduced 1.22%	9,285 $3.34 Million
Q3 2021 Nov 08, 2021	SELL	$310.19 - $376.2 $46,528 - $56,430	-150 Reduced 1.57%	9,400 $3.06 Million
Q2 2021 Jul 22, 2021	SELL	$262.71 - $351.17 $48,601 - $64,966	-185 Reduced 1.9%	9,550 $2.98 Million
Q1 2021 May 13, 2021	SELL	$285.92 - $355.13 $108,649 - $134,949	-380 Reduced 3.76%	9,735 $3.1 Million
Q4 2020 Feb 18, 2021	BUY	$251.88 - $324.2 $2.55 Million - $3.28 Million	10,115 New	10,115 $3.28 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Bradley Mark J., based on Form 13F filings with the SEC.

Stay updated on Bradley Mark J. with notifications on news.